Close Menu

NEW YORK — Proteomics International said Thursday that it has signed a deal with Zotal to be the exclusive distributer of the immunoassay version of its PromarkerD diabetic kidney disease test in Israel.

The agreement is the first that Proteomics International has signed for PromarkerD in the Middle East and follows an Italian distribution agreement it announced in October.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.